Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development a... Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements). Show more
LOS ANGELES, Aug. 08, 2024 (GLOBE NEWSWIRE) -- via IBN β IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.23 | 5.83756345178 | 3.94 | 4.53 | 3.94 | 82292 | 4.09413162 | CS |
4 | -1.71 | -29.0816326531 | 5.88 | 6.04 | 3.85 | 93091 | 4.42401604 | CS |
12 | -1.75 | -29.5608108108 | 5.92 | 6.83 | 3.85 | 77359 | 5.00742828 | CS |
26 | -2.23 | -34.84375 | 6.4 | 9.2 | 3.8181 | 223420 | 6.39663483 | CS |
52 | -4.51 | -51.9585253456 | 8.68 | 12 | 3.8181 | 592854 | 7.31529288 | CS |
156 | -101.83 | -96.0660377358 | 106 | 113.6 | 3.8181 | 540481 | 30.31221703 | CS |
260 | -186.83 | -97.8167539267 | 191 | 356.4 | 3.8181 | 476132 | 54.22045516 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.